SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 352 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,907,000 | +1.1% | 22,610 | -32.7% | 0.02% | 0.0% |
| Q4 2014 | $3,864,000 | -26.1% | 33,614 | +0.5% | 0.02% | -29.0% |
| Q3 2014 | $5,227,000 | +122.2% | 33,453 | +75.4% | 0.03% | +138.5% |
| Q2 2014 | $2,352,000 | +22.2% | 19,071 | +2.7% | 0.01% | +18.2% |
| Q1 2014 | $1,925,000 | -2.8% | 18,577 | -15.6% | 0.01% | 0.0% |
| Q4 2013 | $1,980,000 | +54.8% | 22,011 | +15.1% | 0.01% | +57.1% |
| Q3 2013 | $1,279,000 | +69.9% | 19,130 | +68.0% | 0.01% | +75.0% |
| Q2 2013 | $753,000 | – | 11,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |